.jpg)
22 hours ago
3
Article content
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual and special meeting (the “Meeting”) of holders of common shares (“Shareholders”) held today.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
There were 389 Shareholders represented virtually or by proxy at the Meeting holding an aggregate of 130,357,074 common shares, representing 30.68% of MediPharm’s total issued and outstanding common shares as of the record date for the Meeting. As the Meeting was held virtually, all resolutions were passed by way of ballot. Complete voting results for each of the matters presented at the Meeting are provided below.
Article content
Article content
Article content
Board Changes
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Following his re-election as a director, Keith Strachan was appointed Chair of the Board. Chris Taves, outgoing Chair, and Chris Halyk did not stand for re-election.
Article content
“I am honoured to step into the role of Chair of the Board,” said Keith Strachan, Chair of the Board of MediPharm. “On behalf of the Board, I want to thank our Shareholders for their continued support, and to thank Chris Taves and Chris Halyk for their many contributions and years of service. As a co-founder and former President of MediPharm Labs, I have long believed in the Company’s potential, and I look forward to working with Greg, the management team and my fellow directors as we continue advancing the Company’s path to sustainable profitability across regulated medical cannabis markets.”
Article content
Complete Voting Results from the Meeting
Article content
1. Setting the Number of Directors at Five
Article content
The special resolution to fix the number of directors of the Company at five (5) was approved. Voting results are as set out below:
Article content
| Votes For | Votes Against | ||
| # | % | # | % |
| 125,319,545 | 96.136% | 5,037,529 | 3.864% |
Article content
2. Board Size Authorizing Resolution
Article content
Article content
The special resolution authorizing the directors of the Company to set the number of directors within the minimum and maximum provided in the Company’s articles was approved. Voting results are as set out below:
Article content
| Votes For | Votes Against | ||
| # | % | # | % |
| 123,792,599 | 94.964% | 6,564,474 | 5.036% |
Article content
3. Election of Directors
Article content
Each of the Company’s nominees were elected as directors of MediPharm for the ensuing year or until their successors are elected or appointed. Voting results for each nominee are as set out below:
Article content
| Nominee | Votes For | Votes Withheld | ||
| # | % | # | % | |
| Keith Strachan | 90,271,829 | 88.029% | 12,275,634 | 11.971% |
| David Pidduck | 88,352,005 | 86.157% | 14,195,458 | 13.843% |
| Michael Bumby | 75,187,058 | 73.319% | 27,360,405 | 26.681% |
| Emily Jameson | 94,274,136 | 91.932% | 8,273,327 | 8.068% |
| John Medland | 93,824,321 | 91.494% | 8,723,142 | 8.506% |
Article content
4. Appointment of Auditor
Article content
MNP LLP, Chartered Professional Accountants, was appointed as auditor of the Company until the next annual meeting of Shareholders at remuneration to be fixed by the directors.
Article content
| Votes For | Votes Withheld | ||
| # | % | # | % |
| 127,841,206 | 98.07% | 2,515,868 | 1.93% |
English (US)